| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Sales Management > Don't Tie A Rabbit To A Cow |
|
Useful Advices - Don't Tie A Rabbit To A Cow
When I was first promoted to management, I had to make a very difficult decision. I had been the best According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product salesperson on the crew, and Bud was number two. He and I vied for the management job, and the fact t ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in hat I got it meant that he had to report to me. This irked him. So, when I recruited, trained, and l lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. unched the careers of new salespeople, Bud found a way to poke holes in their boats, to slow them down here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe , to discourage them from challenging his sales supremacy. In essence, my new people never made a cre d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro dible challenge to his informal leadership. He lorded over them, mostly nonverbally, with cold stares ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc and by invading their work areas. I firmly believed he was trying to make himself look good by keeping easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi them down. And, I sensed his notion was if he could destabilize my leadership, by making it appear t nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically hat I wasn’t doing a good job of staffing, training, and motivating, he’d step into my job, sooner or and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ater. This was intolerable, and in the privacy of my office, I set forth my observations, with a chal ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi lenge that he had to pick up his sales and stop torpedoing my crew. He denied everything, calling me ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a paranoid, and effectively, he left in a huff. Later that evening, my boss called for our sales number dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod , and after hearing how paltry they sounded, I explained what had happened, and why. Boldly, I asserte cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin d with Bud out of the way, our overall sales level would rise. His cold reply: “Well, I just hope you tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ’re right.” One way or another, I made it right, and our sales surpassed all previous highs. As far a t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel I’m concerned, Bud, who had been the top producer, was keeping sales down, and for expectations to ri ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust se, for new and better producers to come forth and assert themselves, he needed to be out of the pictu y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products re. Look at your crew. Who is the leader? Ask two questions: (1) Can I afford to lose him? (2) Can . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de I afford to keep him? Consider this homespun saying: You never want to tie a rabbit to a cow to see h elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ow fast the rabbit can run. Look again at your salespeople: Who are the rabbits, and who are the cows tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Introducing Coaching Into an Established Culture How Do Keywords Effect Your Rankings
|